Exchange: TAI Sector: Healthcare Industry: Biotechnology
-0.22% TWD23.15
America/New_York / 3 mai 2024 @ 01:30
FUNDAMENTALS | |
---|---|
MarketCap: | 2 002.74 mill |
EPS: | 0.380 |
P/E: | 60.92 |
Earnings Date: | May 09, 2024 |
SharesOutstanding: | 86.51 mill |
Avg Daily Volume: | 0.181 mill |
RATING 2024-05-03 |
---|
C |
Sell |
RATINGS | ||
---|---|---|
Rating CashFlow: | Strong Sell | |
Return On Equity: | Sell | |
Return On Asset: | Sell | |
DE: | Sell | |
P/E: | Strong Sell | |
Price To Book: | Neutral |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
Revenue | ||||||
Gr.Profit | ||||||
Ebit | ||||||
Asset | ||||||
Debt |
PE RATIO: COMPANY / SECTOR |
---|
3.28x |
Company: PE 60.92 | sector: PE 18.55 |
PE RATIO: COMPANY / INDUSTRY |
---|
4.47x |
Company: PE 60.92 | industry: PE 13.63 |
DISCOUNTED CASH FLOW VALUE |
---|
TWD-13.47 (-158.18%) TWD-36.62 |
Date: 2024-05-05 |
Expected Trading Range (DAY) |
---|
TWD 22.69 - 23.61 ( +/- 1.98%) |
ATR Model: 14 days |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 | |
MACD |
Volume Signals | |
---|---|
Price | TWD23.15 (-0.22% ) |
Volume | 0.153 mill |
Avg. Vol. | 0.181 mill |
% of Avg. Vol | 84.59 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % |
---|
GenMont Biotech Incorporation engages in the research, development, production, and sale of functional probiotic products in Taiwan. The company also offers probiotics with special functions; and original formula design and manufacturing, and equipment manufacturing services on health care food, as well as cooperates in the research, production, and clinical trial of various products. GenMont Biotech Incorporation was founded in 2000 and is headquartered in Tainan City, Taiwan.